When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HLUYY - Lundbeck cuts guidance after failed Parkinson's study
H Lundbeck A/S S/Adr
H. Lundbeck A/S (OTCPK:HLUYY-4.0%) slips on light volume on the heels of its announcement of unsuccessful results from a Phase 2a clinical trial, AMBLED, evaluating foliglurax in Parkinson's disease (PD) patients experiencing motor complications from levodopa therapy.
More news on: H. Lundbeck A/S, H. Lundbeck A/S, Healthcare stocks news, Stocks on the move,